Modafinil Completed Phase 4 Trials for Multiple Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03621761Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue